Overall market sentiment has been down on SpringWorks Therapeutics Inc (SWTX) stock lately. SWTX receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With SWTX Stock Today?
SpringWorks Therapeutics Inc (SWTX) stock is trading at $72.77 as of 3:15 PM on Friday, May 14, a gain of $4.45, or 6.51% from the previous closing price of $68.32. The stock has traded between $68.65 and $73.44 so far today. Volume today is below average. So far 115,964 shares have traded compared to average volume of 248,903 shares.
To see the top 5 stocks in the Biotechnology industry click here.
More About SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc is a United States-based biopharmaceutical company. It is focused on identifying, developing, and commercializing therapies for underserved patient populations suffering from severe rare diseases and cancer. The firm's pipeline product includes Mirdametinib, Nirogacestat, and others.
Click Here to get the full Stock Score Report on SpringWorks Therapeutics Inc (SWTX) Stock.
